Compare Globalstar (GSAT) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globalstar vs ImmunityBio Inc. Common Stock — how do they compare? Globalstar trades at $83.8 (market cap $10.78B), while ImmunityBio Inc. Common Stock trades at $10.51 (market cap $10.51B). The key difference: Globalstar and ImmunityBio Inc. Common Stock are close in size by market cap, and Globalstar is more actively traded (723,953 versus 10,445,785). Which is the better fit depends on your goals — on Pluang, investors hold Globalstar for 21 Days and ImmunityBio Inc. Common Stock for 1 Days on average.
| GSAT | IBRX | |
|---|---|---|
Market Cap | $10.78B | $10.51B |
Volume | 723,953 | 10,445,785 |
Sector | Media | Health |
52-Week High | $84.43 | $11.55 |
52-Week Low | $41.54 | $1.98 |
Typical Hold Time | 21 Days | 1 Days |
Enterprise Value | $10.79B | $10.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Globalstar
Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
